Kodiak Sciences Inc reports results for the quarter ended in December - Earnings Summary

Kodiak Sciences

28/03/2024 21:02

* Kodiak Sciences Inc  KOD.OQ  reported a quarterly adjusted
loss
of $1.13​​ per share for the quarter ended in December, higher
than the same quarter last year, when the company reported EPS
of $-1.35.  The mean expectation of six analysts for the quarter
was for a loss of 77 cents per share. Wall Street expected
results to range from -95 cents to -54 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Kodiak Sciences Inc's reported EPS for the quarter was a
loss of
$1.13​.
    * The company reported a quarterly loss of $59.52 million.
    * Kodiak Sciences Inc shares had risen by 145.1% this
quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 4.9%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 3
"hold" and 3 "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "hold"

Wall Street's median 12-month price target for Kodiak Sciences
Inc is $3.00 
This summary was machine generated from LSEG data March 28 at
09:02 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -0.77          -1.13          Missed
 Sep. 30 2023      -1.21          -0.95          Beat
 Jun. 30 2023      -1.14          -1.53          Missed
 Mar. 31 2023      -1.33          -1.35          Missed